23 Oct 2023
17:45 CEST |
TITAN CEMENT |
Share buyback Programme
|
50101030 Cement |
Other subject |
23 Oct 2023
17:45 CEST |
KINEPOLIS GROUP |
Update inkoopprogramma eigen aandelen (23 oktober 2023)
|
40301010 Entertainment |
Corporate life |
23 Oct 2023
17:45 CEST |
KINEPOLIS GROUP |
Update share buyback program (23 October 2023)
|
40301010 Entertainment |
Corporate life |
23 Oct 2023
17:45 CEST |
KINEPOLIS GROUP |
Mise à jour concernant le programme de rachat d'actions propres (23 octobre 2023)
|
40301010 Entertainment |
Corporate life |
23 Oct 2023
11:00 CEST |
HYBRID SOFTWARE GROUP PLC |
Hybrid Software Group PLC: Result of the Extraordinary General Meeting
|
10101015 Software |
General meeting / Board Meeting |
23 Oct 2023
07:29 CEST |
JENSEN-GROUP |
Inkoop eigen aandelen - wekelijkse update
|
50204000 Machinery: Industrial |
Other subject |
23 Oct 2023
07:29 CEST |
JENSEN-GROUP |
Share buyback – weekly update
|
50204000 Machinery: Industrial |
Other subject |
23 Oct 2023
07:00 CEST |
MITHRA |
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement
|
20103015 Pharmaceuticals |
- |
23 Oct 2023
07:00 CEST |
AZELIS GROUP NV |
Azelis Reinforces Its Footprint in the EMEA Flavors & Fragrances Market With the Acquisition of BLH
|
55201000 Chemicals: Diversified |
Mergers, Acquiqitions, Transferts |
20 Oct 2023
22:00 CEST |
MDXHEALTH |
Mdxhealth's New Share Capital Amount and New Number of Shares
|
20103010 Biotechnology |
Change in Capital |
20 Oct 2023
22:00 CEST |
MDXHEALTH |
Nouveau montant du capital et nouveau nombre d'actions de Mdxhealth
|
20103010 Biotechnology |
Change in Capital |
20 Oct 2023
20:01 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
- |
20 Oct 2023
20:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
|
20103010 Biotechnology |
- |
20 Oct 2023
18:30 CEST |
UMICORE |
Umicore - Déclaration de transparence par BlackRock, Inc.
|
55201020 Specialty Chemicals |
New |
20 Oct 2023
18:30 CEST |
UMICORE |
Umicore - Transparantieverklaring van BlackRock, Inc.
|
55201020 Specialty Chemicals |
New |
20 Oct 2023
18:30 CEST |
UMICORE |
Umicore - Transparency notification by BlackRock, Inc.
|
55201020 Specialty Chemicals |
New |
20 Oct 2023
18:30 CEST |
IEP INVEST |
Buitengewone algemene vergadering van 30 november 2023
|
35101010 Real Estate Holding and Development |
General meeting / Board Meeting |
20 Oct 2023
18:00 CEST |
AZELIS GROUP NV |
Azelis: Transparency Notification
|
55201000 Chemicals: Diversified |
Other subject |
20 Oct 2023
18:00 CEST |
ABO GROUP ENVIRONMENT |
ABO-Group Environment specialiseert zich met overname SWBO in een nieuwe niche
|
50101015 Engineering and Contracting Services |
New |
20 Oct 2023
18:00 CEST |
ABO GROUP ENVIRONMENT |
ABO-Group Environment specialises in new niche with the acquisition of SWBO
|
50101015 Engineering and Contracting Services |
New |
20 Oct 2023
18:00 CEST |
AZELIS GROUP NV |
Azelis: Transparantiekennisgeving
|
55201000 Chemicals: Diversified |
Other subject |
20 Oct 2023
18:00 CEST |
ABO GROUP ENVIRONMENT |
ABO-Group Environment se spécialise dans un nouveau créneau avec l'acquisition de SWBO
|
50101015 Engineering and Contracting Services |
New |
20 Oct 2023
09:17 CEST |
ELIA GROUP |
Elia Group call notice early redemption
|
65101015 Conventional Electricity |
Other financial transaction |
20 Oct 2023
08:15 CEST |
BEKAERT |
Bekaert achève la septième tranche de son Programme de Rachat d'Actions
|
55102010 Iron and Steel |
Legal |
20 Oct 2023
08:15 CEST |
BEKAERT |
Bekaert voltooit de zevende tranche van haar inkoopprogramma eigen aandelen
|
55102010 Iron and Steel |
Legal |
20 Oct 2023
08:15 CEST |
BEKAERT |
Bekaert completes the seventh tranche of its Share Buyback Program
|
55102010 Iron and Steel |
Legal |
20 Oct 2023
08:09 CEST |
SOLVAY |
Solvay announces exercise of issuer call option on the €300 million Perp-NC5.25 hybrid bonds issued by Solvay SA
|
55201000 Chemicals: Diversified |
- |
20 Oct 2023
08:00 CEST |
EURONAV |
Euronav - Special General Meeting of 21 November 2023
|
50206030 Marine Transportation |
Other subject |
20 Oct 2023
08:00 CEST |
EURONAV |
Euronav - Bijzondere Algemene Vergadering van 21 november 2023
|
50206030 Marine Transportation |
Other subject |
20 Oct 2023
07:45 CEST |
EURONAV |
Disclosure regarding a Transparency Notification and Disclosure Regarding a 13D Filing by Famatown Finance Limited & CMB
|
50206030 Marine Transportation |
Other subject |
20 Oct 2023
07:45 CEST |
EURONAV |
OPENBAARMAKING VAN EEN TRANSPARANTIEKENNISGEVING EN KENNISGEVING BETREFFENDE EEN 13D FILING DOOR FAMATOWN FINANCE LIMITED & CMB NV
|
50206030 Marine Transportation |
Other subject |
20 Oct 2023
07:35 CEST |
BPOST |
bpost invites its shareholders to the Special General Meeting of Shareholders
|
50206040 Delivery Services |
Legal |
20 Oct 2023
07:34 CEST |
BPOST |
bpost invites its shareholders to the Special General Meeting of Shareholders
|
50206040 Delivery Services |
Legal |
20 Oct 2023
07:31 CEST |
BPOST |
bpost invites its shareholders to the Special General Meeting of Shareholders
|
50206040 Delivery Services |
Legal |
20 Oct 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)
|
20101025 Health Services |
Other subject |
20 Oct 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Vier abstracts, die uitstekende resultaten voor Idylla™ tonen, worden gepresenteerd op het European Society of Molecular Oncology (ESMO) congres
|
20101025 Health Services |
Other subject |
19 Oct 2023
08:00 CEST |
DMS IMAGING S.A. |
DMS Imaging : Chiffre d'affaires du 3e trimestre 2023 : +22% à 8,9 M EUR .
|
20103010 Biotechnology |
Sales, Income |
18 Oct 2023
17:50 CEST |
CENERGY |
Corinth Pipeworks remporte un contrat de fabrication de tubes pour le projet offshore de capture et de stockage de carbone Porthos aux Pays-Bas
|
50202010 Electrical Components |
News contracts |
18 Oct 2023
17:47 CEST |
CENERGY |
Corinth Pipeworks is awarded a pipe manufacturing contract for the Porthos offshore Carbon Capture & Storage project in the Netherlands
|
50202010 Electrical Components |
News contracts |
18 Oct 2023
14:31 CEST |
BARCO |
Trading update 3Q23
|
10102030 Computer Hardware |
Commercial results |
18 Oct 2023
08:00 CEST |
SOLVAY |
De Raad van Bestuur van Solvay stelt 8 december 2023 vast als datum waarop aandeelhouders kunnen stemmen over de splitsing in twee onafhankelijke beursgenoteerde bedrijven
|
55201000 Chemicals: Diversified |
Corporate life |
18 Oct 2023
08:00 CEST |
SOLVAY |
Solvay Board sets December 8, 2023 for shareholders to vote on the separation into two independent listed companies
|
55201000 Chemicals: Diversified |
Corporate life |
18 Oct 2023
08:00 CEST |
SOLVAY |
Le Conseil d’Administration de Solvay prévoit le vote sur la séparation de Solvay en deux sociétés indépendantes cotées le 8 décembre 2023
|
55201000 Chemicals: Diversified |
Corporate life |
18 Oct 2023
07:00 CEST |
BIOSENIC |
BioSenic va tirer les dernières tranches de son programme actuel d'obligations convertibles Global Tech Opportunities 15 et sécuriser son financement jusqu’à la fin du mois de janvier 2024
|
20103010 Biotechnology |
Alliances and agreements |
18 Oct 2023
07:00 CEST |
ION BEAM APPLICATIONS |
IBA plans total system restoration on its first-ever proton therapy installation
|
20102010 Medical Equipment |
News contracts |
18 Oct 2023
07:00 CEST |
HYLORIS |
Hyloris announces U.S. FDA Approval of Maxigesic® IV
|
20103010 Biotechnology |
Commercial operations |
18 Oct 2023
07:00 CEST |
BIOSENIC |
BioSenic to draw the final tranches of its present Global Tech Opportunities 15 convertible bonds program and secure runway end of January 2024
|
20103010 Biotechnology |
Alliances and agreements |
18 Oct 2023
07:00 CEST |
ION BEAM APPLICATIONS |
IBA signe un contrat pour la modernisation de son premier système de protonthérapie
|
20102010 Medical Equipment |
News contracts |
18 Oct 2023
07:00 CEST |
HYLORIS |
Hyloris annonce l’approbation de Maxigesic® IV par la FDA Américaine
|
20103010 Biotechnology |
Commercial operations |
17 Oct 2023
18:30 CEST |
INTERVEST OFF-WARE |
Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release
|
35102030 Office REITs |
Takeover bids |